◆英語タイトル：ProQR Therapeutics NV (PRQR) - Financial and Strategic SWOT Analysis Review
◆産業分野：Pharmaceuticals and Healthcare
ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide that is designed to treat Leber’s congenital amaurosis; and QR-313, a single-stranded oligonucleotide used for the treatment of epidermolysis bullosa. It develops novel investigational drug called QR-421 for the treatment of usher syndrome, fuchs endothelial corneal dystrophy, dystrophic epidermolysis bullosa, alzheimer’s disease, central nervous system and neuromuscular diseases. The company also offers clinical trial services. It operates through its laboratory and offices located in Leiden. It operates offices in the US and the Netherlands. ProQR is headquartered in Leiden, the Netherlands.
ProQR Therapeutics NV Key Recent Developments
Mar 02,2021: ProQR Announces Webcast of Presentation at Upcoming HC Wainwright Global Life Sciences Conference
Feb 25,2021: ProQR Announces Fourth Quarter and Full Year 2020 Operating and Financial Results
Nov 16,2020: ProQR announces third quarter 2020 operating and financial results
Oct 05,2020: ProQR appoints Naveed Shams, MD, PhD as Chief Scientific Officer
Aug 06,2020: ProQR announces second quarter 2020 operating and financial results
This comprehensive SWOT profile of ProQR Therapeutics NV provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ProQR Therapeutics NV including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
ProQR Therapeutics NV – Key Information
ProQR Therapeutics NV – Overview
ProQR Therapeutics NV – Key Employees
ProQR Therapeutics NV – Key Employee Biographies
ProQR Therapeutics NV – Key Operational Heads
ProQR Therapeutics NV – Major Products and Services
ProQR Therapeutics NV – History
ProQR Therapeutics NV – Company Statement
ProQR Therapeutics NV – Locations And Subsidiaries
ProQR Therapeutics NV
Other Locations & Subsidiaries
Section 2 – Company Analysis
ProQR Therapeutics NV – Business Description
ProQR Therapeutics NV – Corporate Strategy
ProQR Therapeutics NV – SWOT Analysis
SWOT Analysis – Overview
ProQR Therapeutics NV – Strengths
ProQR Therapeutics NV – Weaknesses
ProQR Therapeutics NV – Opportunities
ProQR Therapeutics NV – Threats
ProQR Therapeutics NV – Key Competitors
Section 3 – Company Financial Performance Charts
ProQR Therapeutics NV – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
ProQR Therapeutics NV, Key Information
ProQR Therapeutics NV, Key Ratios
ProQR Therapeutics NV, Share Data
ProQR Therapeutics NV, Major Products and Services
ProQR Therapeutics NV, History
ProQR Therapeutics NV, Key Employees
ProQR Therapeutics NV, Key Employee Biographies
ProQR Therapeutics NV, Key Operational Heads
ProQR Therapeutics NV, Other Locations
ProQR Therapeutics NV, Subsidiaries
ProQR Therapeutics NV, Key Competitors
ProQR Therapeutics NV, SWOT Analysis
ProQR Therapeutics NV, Ratios based on current share price
ProQR Therapeutics NV, Annual Ratios
ProQR Therapeutics NV, Interim Ratios
Capital Market Ratios
| ★海外企業調査レポート[ProQR Therapeutics NV (PRQR)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら